Knockout Round is Closed!
Thank you for all who are voting! This stage of 16 was the toughest round yet, but only 8 drugs will advance one step closer to the title of "Safest Drug Profile" . Can you pick which drug will win it all? Check out our 4 new matchups in our quarterfinal round. Will Victoza be able to overcome Xeljanz? How will Incivek perform against Crestor?
Players of the Match: Both Louis Lima and Sathish Kumar had the highest score of correct answers. Good Job!
Check below to see the results from last weeks matchups and see how others voted.
Surprised by any of the answers? See the actual RxScore for each of these drugs by registering for a complimentary 7 day trial of AdverseEvents Explorer!
|
Eliquis vs. Onglyza Advances to Quaterfinals: Onglyza
|
|
Coumadin vs. Victoza Advances to Quaterfinals: Vicotza
|
|
Sovaldi vs. Gilenya Advances to Quaterfinals: Sovaldi
|
|
Tysabri vs. Incivek Advances to Quarterfinals: Incivek |
|
Crestor vs. Brilinta Advances to Quarterfinals: Crestor |
|
Enbrel vs. Symbicort Advances to Quarterfinals: Enbrel |
|
Plavix vs. Simcor Advances to Quarterfinals: Simcor |
|
Advair vs. Xeljanz Advances to Quarterfinals: Xeljanz |
 |
Jim Davis Executive Vice President
|
